RIVAROXABAN
NDC 42571-345, RIVAROXABAN, tablet, from Micro Labs Limited.
- Product NDC
- 42571-345
- Status
- Listed
- Labeler
- Micro Labs Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208334
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42571-345 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVAROXABAN2.5 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42571-345-05 | 42571034505 | 500 TABLET in 1 BOTTLE (42571-345-05) |
| 42571-345-30 | 42571034530 | 30 TABLET in 1 BOTTLE (42571-345-30) |
| 42571-345-60 | 42571034560 | 60 TABLET in 1 BOTTLE (42571-345-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/481b7802-5093-43e7-bbd9-1532197eb6e6
Use it
Look up 42571-345 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42571-345 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42571-345. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.